The inhibitory effect of a new scFv/tP protein as siRNA delivery system to target hWAPL in cervical carcinoma.

about

A neutralized human LMP1-IgG inhibits ENKTL growth by suppressing the JAK3/STAT3 signaling pathway.Use of single chain antibody derivatives for targeted drug delivery.TAT-mediated si-hWAPL inhibits the invasion and metastasis of cervical cancer stem cells.

P2860

Q38724665-D1CA7E2D-497C-44BA-BB53-366CF09877F6 Q38850046-946696CC-4CF0-44F5-85A0-53A2B8242FD8 Q49180877-C0C202F7-4F6E-4775-B456-0A795BAB9487

P2860

The inhibitory effect of a new scFv/tP protein as siRNA delivery system to target hWAPL in cervical carcinoma.

Item

http://www.wikidata.org/entity/Q42235397

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

The inhibitory effect of a new ...... t hWAPL in cervical carcinoma.

@en

The inhibitory effect of a new ...... t hWAPL in cervical carcinoma.

@nl

type

Item

label

The inhibitory effect of a new ...... t hWAPL in cervical carcinoma.

@en

The inhibitory effect of a new ...... t hWAPL in cervical carcinoma.

@nl

prefLabel

The inhibitory effect of a new ...... t hWAPL in cervical carcinoma.

@en

The inhibitory effect of a new ...... t hWAPL in cervical carcinoma.

@nl

P1476

The inhibitory effect of a new ...... t hWAPL in cervical carcinoma.

@en

P2093

Chunping Ye

http://www.w3.org/2001/XMLSchema#string

Feng Zhang

http://www.w3.org/2001/XMLSchema#string

Hua Tong

http://www.w3.org/2001/XMLSchema#string

Huilin Zhang

http://www.w3.org/2001/XMLSchema#string

Jin Zhu

http://www.w3.org/2001/XMLSchema#string

Yiping Su

http://www.w3.org/2001/XMLSchema#string

Yuan Mao

http://www.w3.org/2001/XMLSchema#string

P2860

VPAC receptor mediated tumor cell targeting by protamine based nanoparticles.

A human Fab-based immunoconjugate specific for the LMP1 extracellular domain inhibits nasopharyngeal carcinoma growth in vitro and in vivo.

Prospective study of human papillomavirus (HPV) types, HPV persistence, and risk of squamous cell carcinoma of the cervix

Safety of immediate reversal of anticoagulation by protamine to reduce bleeding complications after infarct artery stenting for acute myocardial infarction and adjunctive abciximab therapy.

Selection and characterization of human anti-MAGE-A1 scFv and immunotoxin.

A phase 1 trial of recombinant human IL-21 in combination with cetuximab in patients with metastatic colorectal cancer.

Efficacy and toxicity of a CD22-targeted antibody-saporin conjugate in a xenograft model of non-Hodgkin's lymphoma

Epidermal growth factor receptor as a biomarker for cervical cancer.

A review of clinical trials of cetuximab combined with radiotherapy for non-small cell lung cancer

Protamine sulfate-nanodiamond hybrid nanoparticles as a vector for MiR-203 restoration in esophageal carcinoma cells.

P2888

s11010-014-1989-3

P304

77-84

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11010-014-1989-3

http://www.w3.org/2001/XMLSchema#string

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

391

http://www.w3.org/2001/XMLSchema#string

P577

2014-02-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24567178

http://www.w3.org/2001/XMLSchema#string

The inhibitory effect of a new scFv/tP protein as siRNA delivery system to target hWAPL in cervical carcinoma.

about

P2860

P2860

The inhibitory effect of a new scFv/tP protein as siRNA delivery system to target hWAPL in cervical carcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698